Sansure Biotech Inc. (SHA:688289)
China
· Delayed Price · Currency is CNY 19.92
-0.15 (-0.75%)
May 14, 2025, 2:44 PM CST
Sansure Biotech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Net Income | - | - | 363.72 | 1,937 | 2,243 | 2,617 | Upgrade
|
| Depreciation & Amortization | - | - | 115.62 | 89.07 | 53.94 | 26.68 | Upgrade
|
| Other Amortization | - | - | 21.14 | 8.35 | 5.01 | 1.99 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 0.25 | 0.31 | -2.83 | -3.46 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 6.96 | 21.69 | 2.42 | 2.49 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | -315.58 | -79.24 | -81.01 | -22.56 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 4.98 | 45.96 | 18.49 | - | Upgrade
|
| Other Operating Activities | - | - | -29.47 | 271.83 | 36.64 | 45.83 | Upgrade
|
| Change in Accounts Receivable | - | - | 376.54 | -496.51 | -304.14 | -419.38 | Upgrade
|
| Change in Inventory | - | - | -78.3 | -282.1 | -93.03 | -212.07 | Upgrade
|
| Change in Accounts Payable | - | - | -421.3 | 1,022 | 3.12 | 585.72 | Upgrade
|
| Change in Other Net Operating Assets | - | - | -42.16 | 60.85 | 3.84 | 0.94 | Upgrade
|
| Operating Cash Flow | - | - | 43.54 | 2,559 | 1,877 | 2,642 | Upgrade
|
| Operating Cash Flow Growth | - | - | -98.30% | 36.33% | -28.96% | 11692.86% | Upgrade
|
| Capital Expenditures | - | - | -391.35 | -558.83 | -372.86 | -108.67 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.72 | 0.01 | 15.94 | 6.37 | Upgrade
|
| Cash Acquisitions | - | - | -113 | -11.59 | - | - | Upgrade
|
| Investment in Securities | - | - | 1,791 | -642.46 | -834.95 | -1,630 | Upgrade
|
| Other Investing Activities | - | - | 110.03 | 46.13 | 77.88 | 16.33 | Upgrade
|
| Investing Cash Flow | - | - | 1,398 | -1,167 | -1,112 | -1,716 | Upgrade
|
| Short-Term Debt Issued | - | - | 13 | - | - | 55 | Upgrade
|
| Total Debt Issued | - | - | 13 | - | - | 55 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -55 | - | Upgrade
|
| Long-Term Debt Repaid | - | - | -23.91 | -17.18 | -6.27 | - | Upgrade
|
| Total Debt Repaid | - | - | -23.91 | -17.18 | -61.27 | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | -10.91 | -17.18 | -61.27 | 55 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | - | 1,884 | Upgrade
|
| Repurchase of Common Stock | - | - | -122.73 | -257.41 | -200.01 | - | Upgrade
|
| Common Dividends Paid | - | - | -400.46 | -656.93 | -439.89 | -301.27 | Upgrade
|
| Other Financing Activities | - | - | 165 | 15.57 | 12.58 | -27.88 | Upgrade
|
| Financing Cash Flow | - | - | -369.11 | -915.95 | -688.59 | 1,610 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | 0.34 | -10.01 | -34.25 | -44.59 | Upgrade
|
| Net Cash Flow | - | - | 1,073 | 466.24 | 42.01 | 2,492 | Upgrade
|
| Free Cash Flow | - | - | -347.81 | 2,000 | 1,504 | 2,534 | Upgrade
|
| Free Cash Flow Growth | - | - | - | 32.97% | -40.63% | - | Upgrade
|
| Free Cash Flow Margin | - | - | -34.53% | 31.01% | 33.32% | 53.19% | Upgrade
|
| Free Cash Flow Per Share | - | - | -0.59 | 3.42 | 2.56 | 4.59 | Upgrade
|
| Cash Interest Paid | - | - | - | - | 0.32 | - | Upgrade
|
| Cash Income Tax Paid | - | - | 121.48 | 493.44 | 466.25 | 416.33 | Upgrade
|
| Levered Free Cash Flow | - | - | -227.68 | 1,293 | 898.55 | 1,780 | Upgrade
|
| Unlevered Free Cash Flow | - | - | -226.17 | 1,295 | 899.06 | 1,780 | Upgrade
|
| Change in Net Working Capital | -466.25 | - | -35.41 | -323.92 | 371.11 | 58.64 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.